B of A Securities analyst Kevin Fischbeck downgrades Agilon Health (NYSE:AGL) from Buy to Underperform and announces $3 price target.
B of A Securities Downgrades Agilon Health to Underperform, Announces $3 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.